Provision of cancer care during the COVID-19 pandemic

James Spicer; Charlotte Chamberlain; Sophie Papa

doi:10.1038/s41571-020-0370-6

Provision of cancer care during the COVID-19 pandemic

James Spicer^*
, Charlotte Chamberlain
, Sophie Papa

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate (Academic Journal) › peer-review

85 Citations (Scopus)

Abstract

Health-care services are rapidly transforming their organization and workforce in response to the coronavirus disease 2019 (COVID-19) pandemic. These changes, and a desire to mitigate infection risk, are having profound effects on other vital aspects of care, including the care of patients with cancer. Difficult decisions are being made regarding the prioritization of both active treatments and palliative care, despite limited evidence that cancer is an independent risk factor for infection and mortality.

Original language	English
Pages (from-to)	329-331
Number of pages	3
Journal	Nature Reviews Clinical Oncology
Volume	17
Early online date	15 Apr 2020
DOIs	https://doi.org/10.1038/s41571-020-0370-6
Publication status	Published - 1 Jun 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Groups and Themes

Palliative and End of Life Care

Access to Document

10.1038/s41571-020-0370-6

Handle.net

Persistent link

Cite this

@article{c60d2a333f5a4be8b3d6200d503cb22e,

title = "Provision of cancer care during the COVID-19 pandemic",

abstract = "Health-care services are rapidly transforming their organization and workforce in response to the coronavirus disease 2019 (COVID-19) pandemic. These changes, and a desire to mitigate infection risk, are having profound effects on other vital aspects of care, including the care of patients with cancer. Difficult decisions are being made regarding the prioritization of both active treatments and palliative care, despite limited evidence that cancer is an independent risk factor for infection and mortality.",

author = "James Spicer and Charlotte Chamberlain and Sophie Papa",

year = "2020",

month = jun,

day = "1",

doi = "10.1038/s41571-020-0370-6",

language = "English",

volume = "17",

pages = "329--331",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Springer Nature",

}

TY - JOUR

T1 - Provision of cancer care during the COVID-19 pandemic

AU - Spicer, James

AU - Chamberlain, Charlotte

AU - Papa, Sophie

PY - 2020/6/1

Y1 - 2020/6/1

N2 - Health-care services are rapidly transforming their organization and workforce in response to the coronavirus disease 2019 (COVID-19) pandemic. These changes, and a desire to mitigate infection risk, are having profound effects on other vital aspects of care, including the care of patients with cancer. Difficult decisions are being made regarding the prioritization of both active treatments and palliative care, despite limited evidence that cancer is an independent risk factor for infection and mortality.

AB - Health-care services are rapidly transforming their organization and workforce in response to the coronavirus disease 2019 (COVID-19) pandemic. These changes, and a desire to mitigate infection risk, are having profound effects on other vital aspects of care, including the care of patients with cancer. Difficult decisions are being made regarding the prioritization of both active treatments and palliative care, despite limited evidence that cancer is an independent risk factor for infection and mortality.

UR - http://dx.doi.org/10.1038/s41571-020-0370-6

U2 - 10.1038/s41571-020-0370-6

DO - 10.1038/s41571-020-0370-6

M3 - Comment/debate (Academic Journal)

C2 - 32296166

SN - 1759-4774

VL - 17

SP - 329

EP - 331

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

ER -

Provision of cancer care during the COVID-19 pandemic

Abstract

UN SDGs

Research Groups and Themes

Access to Document

Handle.net

Other files and links

Fingerprint

Cite this